Trials / Not Yet Recruiting
Not Yet RecruitingNCT07183813
Acupuncture for Anxiety/Depression in Patients With Breast Cancer
Effects of Acupuncture for Anxiety and/or Depression Among Patients With Breast Cancer
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate the effects and safety of acupuncture on anxiety and/or depression among patients with breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Electroacupuncture group | The needles will be inserted to 15-40mm in acupoints through adhesive pads. Needles will be lifted, thrusted and twirled gently for 3 times to achieve deqi sensation and manipulated every ten minutes during 30-minute maintenance. The electronic acupuncture apparatus will be connected to the bileteral Taiyang, Anmian and Baihui, with a continuous wave of 2 Hertz (Hz) and an electric current of 1-3 milliampere (mA). Participants receive acupuncture treatment three times a week in the first two weeks and twice a week in the last six weeks. |
| DEVICE | Sham electroacupuncture | The needle will be inserted to 2-3mm in Bai Hui acupoint. For the remaining acupoints, needles will be inserted into the pad till reaching but without penetrating the skin. Needles will be lifted, thrusted and twirled gently for 3 times to simulate the effects of the needle tip penetrating the skin. The electronic acupuncture apparatus will be connected to the Baihui acupoint, Shang Yin Tang acupoint, and bilateral An Mian acupoints, with a continuous wave of 2 Hertz (Hz) and an electric current of 0.1-0.3 mA. In about 3-5 seconds, the electric current will be turned down. Participants receive acupuncture treatment three times a week in the first two weeks and twice a week in the last six weeks. |
Timeline
- Start date
- 2025-09-15
- Primary completion
- 2026-09-01
- Completion
- 2026-12-30
- First posted
- 2025-09-19
- Last updated
- 2025-09-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07183813. Inclusion in this directory is not an endorsement.